To investigate whether the CCR5-overexpressing EPC treatment improved the EC function in ApoE−/− mice, we examined plaque content of ECs and the level of the serum NO, a molecule with protective effects in atherosclerosis. The gene discussed is APOE; the disease is atherosclerosis.